Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SWK Holdings ( (SWKH) ) has shared an announcement.
On July 15, 2025, SWK Holdings Corporation and its subsidiary MOD3 Pharma Inc. finalized an asset purchase agreement with AptarGroup, Inc. for the sale of MOD3’s contract manufacturing and development services business assets for approximately $6.9 million. This transaction, initially disclosed in March 2024, reflects SWK Holdings’ strategic move to divest certain assets, potentially impacting its market positioning and operational focus.
The most recent analyst rating on (SWKH) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on SWK Holdings stock, see the SWKH Stock Forecast page.
Spark’s Take on SWKH Stock
According to Spark, TipRanks’ AI Analyst, SWKH is a Outperform.
SWK Holdings is in a solid financial position with strong profitability and strategic initiatives that boost shareholder value. While its technical indicators are neutral, the company’s valuation is appealing, and recent corporate events and earnings calls provide strong positive sentiment.
To see Spark’s full report on SWKH stock, click here.
More about SWK Holdings
SWK Holdings Corporation operates in the pharmaceutical industry, focusing on contract manufacturing, formulation, and development services through its wholly owned subsidiary MOD3 Pharma Inc.
Average Trading Volume: 25,013
Technical Sentiment Signal: Strong Buy
Current Market Cap: $185.9M
For an in-depth examination of SWKH stock, go to TipRanks’ Overview page.